Concept

CGRP receptor antagonists as migraine treatment

Activation of the trigeminovascular system involving calcitonin-gene related peptide (CGRP) release plays a key role in migraine. Small molecule CGRP receptor antagonists known as gepants can treat migraines, and monoclonal antibodies can also target CGRP and its receptors. Studies have shown them to be less effective than triptans.

0

1

Updated 2022-03-12

Tags

Behavioral Neuroscience

Psychology

Neuroscience (Neurobiology)

Social Science

Empirical Science

Science

Life Science / Biology

Biomedical Sciences